“…These data, along with previous studies, lend support for the inclusion of patients, as well as prescribers and pharmacists, as targets for future letter-based interventions. 19,22,24,27 Because this investigation was conducted in the Connecticut Medicaid asthma population, caution should be taken to not overgeneralize the results. Medicaid asthma populations are unlikely to be representative of the general asthma population.…”